Advanced Extraction Systems Inc. Nears Completion on a State of the Art Innovation Centre

Published: May 16, 2019

Industry pioneer and trailblazer, Advanced Extraction Systems Inc. (AESI) announce their new world class innovation centre.

David Campbell, Co-Founder and COO of AESI stated, “In order to meet increasing production demand, we are pleased to announce that our new state of the art production facility will be completed in the coming months. The new manufacturing, R&D, and testing facility will allow for increased vertical integration ensuring the highest level of quality that’s expected from an industry leader.”

Recently AESI released production capacities for their newest system, the Largest CO2 Supercritical Fluid Extraction System for the Global Hemp & Cannabis Industries. “This expansion will take us to the next level as we continue to separate ourselves from the competition. The response has been immense on our newest system in the AESI lineup, the 4 x 1000L, and our new production facility will carry us through the next phase of expansion” states David Campbell. Mr. Campbell continues, “AESI continues to be a trailblazer in the industry with projected growth that has attracted international investors expecting to capitalize on the future success of the company.”

Advanced Extraction Systems Inc. designs, engineers and fabricates supercritical fluid CO2 extraction systems with a specific focus in the medical/recreational marijuana and hemp industries. AESI has assembled a skilled management team and a world-class scientific advisory group with over 75 years of experience in supercritical fluid design and processes. AESI offers the cleanest, most advanced CO2 extraction processes that are leading edge due to the companies ongoing internal focus on research and development. AESI CO2 extraction systems are unique in design, efficiency, and ease of operation. Specifically, AESI systems can be differentiated from the competition in 6 key technical areas; better pump reliability, superior flow rates, superior fractionation, more phase management control, cGMP recipe development, and scalability for future growth.